Direct answer. Many people with heart disease can take part in suitable physical activity. The safe type, effort and progression depend on the actual condition, symptoms and treatment. Daily movement, a structured exercise plan and competitive sport are different decisions; a general activity target cannot give personal medical clearance. NHLBI physical-activity precautions, March 24, 2022; taxonomy anomaly excluded.
- An activity plan should fit the diagnosis and current symptoms.
- A walking pace or weight that is easy for one person may be demanding for another.
- New chest symptoms, major breathlessness or collapse need an urgent response.
- A new illness, hospital admission or medicine change can require reassessment.
- Heart and diabetes medicines, bleeding risk and fluid advice belong in the exercise discussion.
Evidence summary
| Question | Source role | Conclusion and confidence |
|---|---|---|
| Is one exercise plan safe for every heart condition? | Condition-specific clinical education | No. Symptoms, treatment and the actual activity need consideration. |
| Does improved fitness exclude a heart problem? | Outcome distinction | No. Fitness and the underlying disease are different questions. |
| Can a generic home video replace assessment? | Current provider precautions | No. Changing symptoms or lack of assessment require clinical contact. |
| Do medicines affect the discussion? | Selected current and dated safety originals | Yes. Rate, dizziness, bleeding, glucose and fluid plans matter. |
| Are home and centre programmes equally safe? | Current guideline uncertainty | Rare-harm comparisons remain uncertain; setting needs assessment. |
Confidence is high in the need for condition-specific assessment and urgent attention to warning signs; recommendations are attributed clinical context, not independently certified treatment effects. The treatment section attributes clinical guidance; it does not certify the funding of every underlying intervention trial. Independent comparative outcome certainty and a supplement replacement regimen were not established by this focused review. A public institution or independent review cannot make a sponsored original trial financially independent.
Daily movement, structured exercise and cardiac rehabilitation
Physical activity includes movement in daily life, such as walking, gardening or household tasks. Exercise is planned and structured activity. A person who struggles with ordinary movement may need a different discussion from someone asking about a competitive event. Both deserve a plan that addresses the actual concern. NHLBI physical activity definition, March 24, 2022.
A useful goal might be reaching a shop, climbing familiar stairs or returning to a valued activity. Those goals are different from completing a commercial challenge. NHLBI places activity within wider heart care; it does not establish that more exertion always means better health for an individual with a cardiac diagnosis. NHLBI physical activity definition, March 24, 2022.
Cardiac rehabilitation connects suitable activity with education, medicines and recovery support. NHS coronary-recovery information describes tailoring for fitness, age and other medical issues. Ask whether rehabilitation is appropriate locally rather than assuming a gym class supplies the same assessment or clinical contact. NHS coronary recovery, January 17, 2024.
Aerobic activity, strength, balance and relative effort
Aerobic activity uses large muscles and increases breathing and heart work. Strength, balance and flexibility activity address other aspects of physical function. NHLBI distinguishes these purposes. A list of activity categories is not permission to perform every listed example after heart surgery or with a rhythm disorder. NHLBI activity types and relative effort, March 24, 2022.
The effort of an activity is relative to the person. The same walk can feel light to one person and strenuous to another. Discuss how the team will judge suitable effort; copying someone else’s speed, distance or weights is a poor substitute for an assessed plan. NHLBI activity types and relative effort, March 24, 2022.
NHLBI describes adaptation in circulation and the ability to carry out daily tasks. These explanations support why activity is discussed in care. A proposed mechanism or improved performance does not prove that an individual’s blockage, valve lesion or inherited arrhythmia has disappeared. NHLBI activity mechanisms and daily-function context, March 24, 2022.
Different plans for angina, heart failure, AF and implanted devices
For angina, activity needs to fit symptom control. NHS advice supports an active lifestyle within symptom limits and discussion before a new activity. Know the prescribed plan for an attack. Do not reinterpret pain during exercise as a normal training effect or independently change rescue medicines. NHS angina, March 18, 2025.
For heart failure, the current NHS framework includes assessment and an exercise plan within rehabilitation. The condition can vary over time. A plan agreed when stable needs review if symptoms worsen; difficult activity should not automatically be blamed on lack of effort. NHS heart failure, June 26, 2026; selected night-breathlessness context.
With atrial fibrillation, NHS advice distinguishes regular activity from intense exertion or exercising during rhythm symptoms. Ask which activities fit the actual rhythm and treatment plan. Palpitations do not identify the rhythm at home, and an episode should not be managed by testing how hard you can continue. NHS atrial fibrillation, January 13, 2025.
After ICD implantation, healing and device-specific instructions matter as well as the underlying disease. CUH aftercare describes post-implant activity restrictions and calls its leaflet a basis for discussion. A device can treat selected dangerous rhythms without clearing every exercise or protecting against all cardiac events. Follow the implant team’s current advice. CUH ICD aftercare, approved June 27, 2025 version7.
Sustainable activity, tracking and supplement claims
Sustainable movement requires an environment that fits the person. NHLBI suggests considering weather, safe routes, equipment and gradual progress. An activity approved in one setting may become less practical in extreme weather, on uneven ground or without access to help. Discuss alternatives instead of forcing the original plan. NHLBI starting and sustaining activity, March 24, 2022.
Keeping an activity record can help describe patterns and progress. Record what you did, how it felt and any symptoms; a step count alone omits these details. NHLBI presents tracking as a motivational tool, not a diagnostic test or a guarantee that a particular daily score is safe. NHLBI starting and sustaining activity, March 24, 2022.
No pre-workout blend, electrolyte product or heart-support supplement has been independently established here to replace cardiac care or clear exercise. Furosemide education identifies possible interactions with potassium-increasing products and other medicines. Check exact ingredients and prescriptions before adding a product to support a training session. NHS furosemide, July 7, 2026; selected hydration and interaction context.
Assessment, home videos and programme safety limits
A useful plan describes the activity, suitable effort, progression, review and response to symptoms. Bring previous limits and the activities you want to resume. The current CUH assessment example asks about prescriptions and individual needs. Its local appointment details are examples, rather than a required worldwide protocol. CUH current 2026 pre-assessment and changing-symptom information.
Home resources can belong to continuing clinical care. CUH asks people who have not been assessed, or whose symptoms, illness or injuries have changed, to contact the team before starting. Choosing a video with a hospital logo does not itself establish suitability. CUH current home-exercise assessment condition; video charity funding stated.
The 2026 ESC rehabilitation guideline says studies comparing home and centre programmes cannot reliably exclude differences in rare cardiovascular harm. Setting should follow assessment. This guide does not supply a financially cleared event-reduction percentage, equal-safety claim or ranking of programmes. Actual ESC cardiac rehabilitation guideline, August 2026, DOI ehag099; selected sections.
Chest symptoms, breathing emergencies and deterioration
New concerning chest discomfort with breathlessness, sweating, nausea or spreading pain needs emergency attention. Severe breathing difficulty or collapse also needs an emergency response. Stop the activity; a fitness goal, reassuring tracker reading or previous exercise assessment is not a reason to delay help. NHLBI heart-attack symptoms, March 24, 2022.
For known angina, follow the rescue and emergency instructions provided by the treating team. NHS advice also calls for review when the pattern changes or attacks become more frequent. This article gives no replacement dose or waiting-time algorithm, and no rule requiring unfamiliar chest symptoms to follow a familiar pattern. NHS angina, March 18, 2025.
Breathlessness during ordinary activity or lying down, sudden weight gain or other deterioration can require prompt heart-failure assessment. Severe breathing difficulty or impaired responsiveness is an emergency. Do not wait for the next scheduled class to report a significant change. NHS heart failure, June 26, 2026; selected night-breathlessness context.
Heart-rate medicines, bleeding, glucose and fluid plans
Beta blockers slow the heartbeat and can cause dizziness or fatigue. That makes the actual medicine relevant when reviewing effort or a change in exercise tolerance. Do not omit a prescription to reach a higher pulse or self-adjust because a tracker target looks difficult. Ask the clinician how the plan accounts for treatment. NHS beta blockers, actual September 4, 2026 original.
Anticoagulants increase bleeding concerns after injury. The NHS says the treating team may advise avoiding contact sports. Discuss the actual activity, falls and impact risk; the decision differs from whether ordinary walking is appropriate. Equipment cannot automatically remove the consequences of a collision. NHS anticoagulant injury and contact-sport considerations, September 9, 2024.
If diabetes treatment can cause low glucose, exercise and food timing may require a coordinated plan. The dated NHS original identifies exercise as one contributor. This article supplies no glucose threshold, carbohydrate amount or insulin adjustment. Ask the diabetes team how the activity plan and cardiac plan fit together. NHS hypoglycaemia, August 3, 2023; review overdue.
Furosemide can cause thirst or dizziness, and fluid advice depends on the reason for treatment. A generic instruction to drink large amounts or restrict fluids cannot substitute for that plan. Review changing symptoms and exact combinations with the team instead of skipping the medicine for a workout. NHS furosemide, July 7, 2026; selected hydration and interaction context.
Acute illness, specialist clearance and significant injuries
Avoid beginning or intensifying training through a new acute illness or worsening cardiac symptoms. ESC’s current framework identifies unstable conditions requiring assessment, including acute inflammatory heart disease, decompensated heart failure and important untreated rhythm or valve problems. It is not a home checklist for self-clearance. Actual ESC cardiac rehabilitation guideline, August 2026, DOI ehag099; selected sections.
Avoid treating one adult exercise article as competitive-sport, paediatric or pregnancy clearance. The particular condition can require specialist advice. Ask which limits apply now and what would allow review, rather than assuming either unrestricted exertion or permanent inactivity from the diagnosis name alone.
If taking an anticoagulant, a significant head blow, major accident or bleeding that cannot be stopped needs immediate medical attention. Report the medicine. Do not continue the session or use the absence of an obvious wound as reassurance after an important injury. NHS anticoagulant bleeding and injury warnings, September 9, 2024.
Activity goals, review and return to physical work
There is no universal heart-disease exercise dose here. Before a visit, identify the activity you want to perform, current symptoms, recent admissions, medicines and practical barriers. CUH’s current preparation page asks people with worsening symptoms or recent illness to contact the team before a session. CUH current 2026 pre-assessment and changing-symptom information.
Agree how changes will be communicated and when the plan is reviewed. If pain, breathlessness or fatigue prevents a task that was previously manageable, describe the change rather than only reporting fewer steps. Ask who reviews it when cardiology, primary care and rehabilitation share responsibility.
Return to physically demanding work needs its own discussion. NHS coronary-recovery advice notes that heavy exertion may require job adjustments. A comfortable leisure walk does not automatically clear repeated lifting, heat exposure or a long shift. Bring a description of the actual duties to the clinician. NHS coronary recovery, January 17, 2024.
Adaptation mechanisms versus personal limits and proven outcomes
Animal, cellular and physiological findings may explain adaptations to activity. They cannot provide a personal training limit, prove a damaged valve has healed or establish a commercial supplement’s benefit. Fitness, daily function, symptoms and cardiovascular events are different outcomes. Manufacturer-funded or supplied-product outcomes remain Tier 4/Grade D for independence, including within public reviews; none provides an independently certified benefit estimate here.
Funding and source roles
Who paid for the evidence?
Follow named sources to the funding and relationships disclosed in this article. Numbered article disclosures preserve notes where a source is not identified. A public or university name alone does not establish independence.
View 24 more funding disclosures
This graphic reorganizes the article's disclosures; it is not a new financial audit or independence classification. Highlighted notes show different funding relationships where available. Review funding is separate from underlying trial funding. Disclosure is not proof of falsehood, and no declared conflict is not proof of complete independence.
Exercise is an activity and care component, not a single owned product. Providers, trackers, classes, supplements and equipment have separate commercial interests. Public educational funding and institutional accounts do not clear all underlying studies. Hospital charity support is traced separately from national NHS finances; assessment and safety context do not imply endorsement of a paid programme or video routine.
The clinical subject has no single corporate owner; medicines, devices and supplements have separate commercial ownership and financial interests. Medicines, diagnostics, devices, procedures and marketed supplements create different revenue incentives. This describes financial interests rather than misconduct. Funding tier evaluates proximity to the subject; A–D credibility assesses transparency, accuracy incentives and remaining uncertainty. An unresolved link stays unresolved, and a provisional public-information label does not clear the trials behind it.
| Source | Funding / backers | Country / jurisdiction | Independence | Credibility / incentives / gaps |
|---|---|---|---|---|
| NHLBI physical activity definition, March 24, 2022 | NIH/HHS appropriations and permitted gifts. Exact authors, study support and page allocation unclosed. | United States; NHLBI, Bethesda, Maryland; original-study jurisdictions unclosed. | Tier 1 public education route, provisional; original efficacy finance unclassified. | C provisional — actual March 2022 selected body read. Public-care accuracy incentive; dated education and full study finances unclosed. Population suggestions are not personal training targets. Role: Movement versus planned training, not personal eligibility. |
| NHLBI activity types and relative effort, March 24, 2022 | NIH/HHS appropriations and permitted gifts. Exact authors, study support and page allocation unclosed. | United States; NHLBI, Bethesda, Maryland; original-study jurisdictions unclosed. | Tier 1 public education route, provisional; original efficacy finance unclassified. | C provisional — actual March 2022 selected body read. Public-care accuracy incentive; dated education and full study finances unclosed. Population suggestions are not personal training targets. Role: Relative effort and distinct aerobic/strength/balance purposes. |
| NHLBI activity mechanisms and daily-function context, March 24, 2022 | NIH/HHS appropriations and permitted gifts. Exact authors, study support and page allocation unclosed. | United States; NHLBI, Bethesda, Maryland; original-study jurisdictions unclosed. | Tier 1 public education route, provisional; original efficacy finance unclassified. | C provisional — actual March 2022 selected body read. Public-care accuracy incentive; dated education and full study finances unclosed. Population suggestions are not personal training targets. Role: Selected physiological and daily-function context; event efficacy excluded. |
| NHLBI physical-activity precautions, March 24, 2022; taxonomy anomaly excluded | NIH/HHS appropriations and permitted gifts. Exact authors, study support and page allocation unclosed. | United States; NHLBI, Bethesda, Maryland; original-study jurisdictions unclosed. | Tier 1 public education route, provisional; original efficacy finance unclassified. | C provisional — actual March 2022 body read. Public-care accuracy incentive; dated general education, no individual exercise clearance or outcome estimate. Risk page incorrectly groups myocarditis under congenital problems; that taxonomy is excluded. Role: Selected exertional-symptom and condition-specific review; taxonomy anomaly excluded. |
| NHLBI starting and sustaining activity, March 24, 2022 | NIH/HHS appropriations and permitted gifts. Exact authors, study support and page allocation unclosed. | United States; NHLBI, Bethesda, Maryland; original-study jurisdictions unclosed. | Tier 1 public education route, provisional; original efficacy finance unclassified. | C provisional — actual March 2022 selected body read. Public-care accuracy incentive; dated education and full study finances unclosed. Population suggestions are not personal training targets. Role: Practical environment, tracking and gradual-plan context. |
| NHS coronary recovery, January 17, 2024 | National NHS own accounts and editorial policy. Contributor, original-study and exact page funding unclosed. | United Kingdom; national NHS England, Leeds contact. Full contributor and study jurisdictions unclosed. | Tier 1 national public education, provisional; original-trial independence unclassified. | B provisional — actual dated selected body read. Public-care accuracy incentive; simplified education and full original-study finances unclosed. No home dose, clearance, numerical outcome or universal activity timetable. Role: Tailored coronary recovery and return-to-work discussion. |
| NHS angina, March 18, 2025 | National NHS own accounts and editorial policy. Contributor, original-study and exact page funding unclosed. | United Kingdom; national NHS England, Leeds contact. Full contributor and study jurisdictions unclosed. | Tier 1 national public education, provisional; original-trial independence unclassified. | B provisional — actual dated selected body read. Public-care accuracy incentive; simplified education and full original-study finances unclosed. No home dose, clearance, numerical outcome or universal activity timetable. Role: Exertional symptom limits and prescribed emergency plan. |
| NHS atrial fibrillation, January 13, 2025 | National NHS own accounts and editorial policy. Contributor, original-study and exact page funding unclosed. | United Kingdom; national NHS England, Leeds contact. Full contributor and study jurisdictions unclosed. | Tier 1 national public education, provisional; original-trial independence unclassified. | B provisional — actual dated selected body read. Public-care accuracy incentive; simplified education and full original-study finances unclosed. No home dose, clearance, numerical outcome or universal activity timetable. Role: Rhythm symptoms and individualized activity discussion. |
| NHS heart failure, June 26, 2026; selected night-breathlessness context | National NHS England 2025–26 accounts and editorial policy. Specific allocation, contributors and underlying-trial finance unclosed. | United Kingdom; national NHS England, Leeds contact. Full contributor and study jurisdictions unclosed. | Tier 1 national public education, provisional; original-trial independence unclassified. | B provisional — actual dated body read selectively. Public-care accuracy incentive; simplified local pathways, full trial funding unclosed. No home threshold, survival estimate or driving-law transfer. Role: Current assessed heart-failure activity and deterioration signs. |
| NHS beta blockers, actual September 4, 2026 original | National NHS England: actual 2025–26 audited accounts documents DHSC grant-in-aid as principal finance plus service, education/research and other consolidated income. content policy rejects advertising/corporate sponsorship. Exact page budget, contributor and underlying-trial financial chain unresolved; provider trusts have separate finances. | United Kingdom; national England patient information, institutional contact Leeds; local services and driving rules vary. | Tier 1 public education provisional; supporting trial/author finance unclassified. | B provisional — actual September 4, 2026 original read; attributed medicine purpose, safety and monitoring only. Public-care accuracy/accountability incentives; named contributors, page allocation and underlying drug-trial finance unclosed. No independent efficacy ranking, personal dose or universal review timetable. Role: Current slowing-heartbeat mechanism, dizziness and medicine review. |
| NHS anticoagulant injury and contact-sport considerations, September 9, 2024 | National NHS own accounts and editorial policy. Contributor, original-study and exact page funding unclosed. | United Kingdom; national NHS England, Leeds contact. Full contributor and study jurisdictions unclosed. | Tier 1 national public education, provisional; original-trial independence unclassified. | B provisional — actual dated selected body read. Public-care accuracy incentive; simplified education and full original-study finances unclosed. No home dose, clearance, numerical outcome or universal activity timetable. Role: Contact/injury risk with anticoagulants. |
| NHS anticoagulant bleeding and injury warnings, September 9, 2024 | National NHS England: actual 2025–26 audited accounts documents DHSC grant-in-aid as principal finance plus service, education/research and other consolidated income. content policy rejects advertising/corporate sponsorship. Exact page budget, contributor and underlying-trial financial chain unresolved; provider trusts have separate finances. | United Kingdom; national England patient information, institutional contact Leeds; local services and driving rules vary. | Tier 1 public education provisional; supporting trial/author finance unclassified. | B provisional — actual September 9, 2024 original body read. Public-care accuracy/accountability incentives; attributed purpose, monitoring and safety education only. Exact page allocation, named contributor and underlying original-drug-trial financial chains remain unclosed. No comparative efficacy clearance, personal dose or universal monitoring/stop timetable. Role: Immediate attention after significant head injury or major bleeding. |
| NHS hypoglycaemia, August 3, 2023; review overdue | National NHS own accounts and editorial policy. Contributor, original-study and exact page funding unclosed. | United Kingdom; national NHS England, Leeds contact. Full contributor and study jurisdictions unclosed. | Tier 1 national public education, provisional; original-trial independence unclassified. | C provisional — actual August 3, 2023 selected safety body read; scheduled review overdue. Exercise and diabetes plans need individualized review. Thresholds, dose changes and home glucose algorithms excluded. Role: Dated exercise/glucose and consciousness precautions, no home dose algorithm. |
| NHS furosemide, July 7, 2026; selected hydration and interaction context | National NHS own accounts and editorial policy. Contributor, original-study and exact page funding unclosed. | United Kingdom; national NHS England, Leeds contact. Full contributor and study jurisdictions unclosed. | Tier 1 national public education, provisional; original-trial independence unclassified. | C provisional — actual July 7, 2026 selected safety body read; fluid advice and exact combinations need individualized review. Thresholds, dose changes, rarity reassurance and universal fluid volumes excluded. Role: Current hydration and exact-combination considerations. |
| CUH current 2026 pre-assessment and changing-symptom information | Separate provider 2025–26 NHS/private/research/training/donation accounts. Page, contributors and study financing unclosed. | United Kingdom; Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge. ACT donation route; complete backer jurisdictions unclosed. | Tier 2 mixed provider education, provisional; original efficacy unclassified. | C provisional — actual current selected body read. Specialist-care accuracy and service incentives; print date is not clinical revision, full contributor/trial finance unclosed. Local drug timing, glucose thresholds, programme rules and outcome claims excluded. Role: Current provider preparation and changing-symptom contact example. |
| CUH current home-exercise assessment condition; video charity funding stated | Separate provider 2025–26 NHS/private/research/training/donation accounts. Page, contributors and study financing unclosed. Original names ACT as video funder; donation route. Named donors and video allocation unclosed; video routines not adopted. | United Kingdom; Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge. ACT donation route; complete backer jurisdictions unclosed. | Tier 2 mixed provider education, provisional; original efficacy unclassified. | C provisional — actual current selected body read. Specialist-care accuracy and service incentives; print date is not clinical revision, full contributor/trial finance unclosed. Local drug timing, glucose thresholds, programme rules and outcome claims excluded. Role: Assessment before using resources and named video funding. |
| CUH own ACT donation and service-support description; full charity ledger unclosed | Actual provider description identifies ACT donations supporting services, research and equipment beyond NHS funding. Complete current charity ledger, named donors and video-specific allocation not retrieved. | United Kingdom; Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge. ACT donation route; complete backer jurisdictions unclosed. | Tier 3 provider/charity financial self-description. | C provisional — actual donation/support body read. Fundraising and reputation incentives; full accounts/backers unclosed. Finance only. Role: Actual donation/support route; not exercise efficacy. |
| CUH ICD aftercare, approved June 27, 2025 version7 | Cambridge University Hospitals NHS Foundation Trust: actual 2025–26 audited accounts documents NHS commissioner, private-patient, research/training, donation and other service income. NIHR infrastructure and industry/charity research channels disclosed; exact leaflet allocation, contributor/device-study financial chain unresolved. | United Kingdom; Cambridge University Hospitals, Addenbrooke’s/TheRosie, HillsRoad, Cambridge, England; actual original contact checked. | Tier 2 provider clinical education; full contributor and device-study finance unclassified. | B provisional — actual dated/approved original read; specialist care accountability, provider incentives and unknown contributor/device-trial ties. Strict arm-immobilization, travel, car-charging and generic equipment restrictions not adopted; individual advice needed. Role: Device-specific healing and exercise review. |
| CUH actual audited 2025–26 accounts | Cambridge University Hospitals NHS Foundation Trust: actual 2025–26 audited accounts documents NHS commissioner, private-patient, research/training, donation and other service income. NIHR infrastructure and industry/charity research channels disclosed; exact leaflet allocation, contributor/device-study financial chain unresolved. | United Kingdom; Cambridge University Hospitals, Addenbrooke’s/TheRosie, HillsRoad, Cambridge, England; actual original contact checked. | Tier 3 institutional financial self-report. | B provisional — actual197page audited institutional report read; statutory accountability, own reporting and no page allocation. Finance only. |
| Actual ESC cardiac rehabilitation guideline, August 2026, DOI ehag099; selected sections | Preamble states ESC development funding without healthcare-industry involvement; society income includes industry partnerships. Separate author report and trial chains not retrieved. | France; ESC association, Sophia Antipolis; multinational clinical panel. | Tier 2 professional framework, provisional; full author/trial finance unclassified. | C provisional — actual selected August 2026 scope, assessment, contraindication and uncertainty passages read. Professional accuracy/reputation incentives; full separate declarations and source-trial finances unclosed. Care context, no benefit rates or personal criteria. Role: Selected current adult safety and home-programme uncertainty. |
| ESC actual current institutional income model; annual 2026 PDF unavailable | Actual institutional page lists membership, scientific events, publication/education/accreditation and life-science/medtech partnership income. Statutory-audit claim is self-reported. Annual 2026 PDF exceeded access limit; totals and page allocations not verified. | France; ESC European Heart House, Sophia Antipolis. Multinational ESC/ERA collaboration; full study/supplier jurisdictions unresolved. | Tier 3 institutional financial self-report. | B provisional for actual stated income routes; institution has commercial and professional incentives, complete donor/contract and publication allocations unclosed. Financial role only. Role: Actual society income and industry routes. |
| NHLBI heart-attack symptoms, March 24, 2022 | US federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved. | United States; NIH/NHLBI, Bethesda, Maryland; federal jurisdiction. | Tier 1 public education provisionally; donation route and page-specific chain unresolved. | C provisional — actual 2022/2024 original body read selectively. Public educational accuracy incentive; dated generalizations and full source/underlying-trial financial gaps. Relative sex/race outcome claims, surgical-menopause simplification, blanket HRT harm, fixed risk tools/ages, symptom-severity reassurance and dose instructions excluded. Selected attributed warning signs, diagnostic purpose and care questions only. Role: Emergency cardiac symptom recognition. |
| NHS England actual audited 2025–26 accounts | National NHS England: actual 2025–26 audited accounts documents DHSC grant-in-aid as principal finance plus service, education/research and other consolidated income. content policy rejects advertising/corporate sponsorship. Exact page budget, contributor and underlying-trial financial chain unresolved; provider trusts have separate finances. | United Kingdom; national England patient information, institutional contact Leeds; local services and driving rules vary. | Tier 3 institutional financial self-report. | B provisional for actual statutory financial channels; no page/trial allocation or complete donor chain. |
| NHS anticoagulants versus antiplatelets, September 9, 2024 | National NHS England: actual 2025–26 audited accounts documents DHSC grant-in-aid as principal finance plus service, education/research and other consolidated income. content policy rejects advertising/corporate sponsorship. Exact page budget, contributor and underlying-trial financial chain unresolved; provider trusts have separate finances. | United Kingdom; national England patient information, institutional contact Leeds; local services and driving rules vary. | Tier 1 public education provisional; supporting trial/author finance unclassified. | B provisional — actual September 9, 2024 reviewed original opened. Public-care accountability and review dating support attributed medicine/safety education. Named contributor, exact page allocation and complete original-drug-trial finance unresolved; no independent comparative efficacy clearance. Doses and universal long-term schedules not adopted. Role: Additional original linked in condition-specific education or follow-up. |
| NHLBI budget | US federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved. | United States; NIH/NHLBI, Bethesda, Maryland; federal jurisdiction. | Tier 3 institutional financial self-disclosure. | B provisional. Direct public financial policy, with legal accountability; actual gift donors and allocations not audited. Financial provenance only. |
| NHLBI Gift Fund | US federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved. | United States; NIH/NHLBI, Bethesda, Maryland; federal jurisdiction. | Tier 3 institutional financial self-disclosure. | B provisional. Direct public financial policy, with legal accountability; actual gift donors and allocations not audited. Financial provenance only. |
| NHS national website funding policy | DHSC funds the national NHS website; its policy states no advertising or corporate sponsorship. Named authors, page-level budget and full underlying trial conflicts unresolved. | United Kingdom; England national public-information service. Other jurisdictions have different services. | Tier 3 editorial and financial self-disclosure. | B provisional. Explicit funding policy; actual individual declarations and implementation not audited. Financial provenance only. |
Frequently asked questions
Can I walk if I have heart disease? Many people can undertake suitable activity; the actual condition and symptoms determine the plan.
Are weights forbidden for every heart patient? No blanket rule is supplied. Ask about the activity, effort and recovery restrictions.
Can a wearable give exercise clearance? No. A score or pulse reading cannot replace assessment or symptom review.
Can I exercise through angina or palpitations? Follow the prescribed symptom plan and seek appropriate assessment; do not push through a new concerning symptom.
Should I drink extra water while taking a diuretic? Fluid advice must fit the reason for treatment; no universal volume is given.
Does becoming fitter mean I can stop medicines? No. Prescription changes require review of the actual condition.
Sources and funding notes
- NHLBI physical activity definition, March 24, 2022 — Movement versus planned training, not personal eligibility.
- NHLBI activity types and relative effort, March 24, 2022 — Relative effort and distinct aerobic/strength/balance purposes.
- NHLBI activity mechanisms and daily-function context, March 24, 2022 — Selected physiological and daily-function context; event efficacy excluded.
- NHLBI physical-activity precautions, March 24, 2022; taxonomy anomaly excluded — Selected exertional-symptom and condition-specific review; taxonomy anomaly excluded.
- NHLBI starting and sustaining activity, March 24, 2022 — Practical environment, tracking and gradual-plan context.
- NHS coronary recovery, January 17, 2024 — Tailored coronary recovery and return-to-work discussion.
- NHS angina, March 18, 2025 — Exertional symptom limits and prescribed emergency plan.
- NHS atrial fibrillation, January 13, 2025 — Rhythm symptoms and individualized activity discussion.
- NHS heart failure, June 26, 2026; selected night-breathlessness context — Current assessed heart-failure activity and deterioration signs.
- NHS beta blockers, actual September 4, 2026 original — Current slowing-heartbeat mechanism, dizziness and medicine review.
- NHS anticoagulant injury and contact-sport considerations, September 9, 2024 — Contact/injury risk with anticoagulants.
- NHS anticoagulant bleeding and injury warnings, September 9, 2024 — Immediate attention after significant head injury or major bleeding.
- NHS hypoglycaemia, August 3, 2023; review overdue — Dated exercise/glucose and consciousness precautions, no home dose algorithm.
- NHS furosemide, July 7, 2026; selected hydration and interaction context — Current hydration and exact-combination considerations.
- CUH current 2026 pre-assessment and changing-symptom information — Current provider preparation and changing-symptom contact example.
- CUH current home-exercise assessment condition; video charity funding stated — Assessment before using resources and named video funding.
- CUH own ACT donation and service-support description; full charity ledger unclosed — Actual donation/support route; not exercise efficacy.
- CUH ICD aftercare, approved June 27, 2025 version7 — Device-specific healing and exercise review.
- CUH actual audited 2025–26 accounts — Actual separate hospital finances, selected operating-income notes.
- Actual ESC cardiac rehabilitation guideline, August 2026, DOI ehag099; selected sections — Selected current adult safety and home-programme uncertainty.
- ESC actual current institutional income model; annual 2026 PDF unavailable — Actual society income and industry routes.
- NHLBI heart-attack symptoms, March 24, 2022 — Emergency cardiac symptom recognition.
- NHS England actual audited 2025–26 accounts — National institutional accounts, not provider video funding.
- NHS anticoagulants versus antiplatelets, September 9, 2024 — Additional original linked in condition-specific education or follow-up.
- NHLBI budget — Financial provenance only.
- NHLBI Gift Fund — Financial provenance only.
- NHS national website funding policy — Financial provenance only.
The selected clinical originals and institutional financial sources were opened, with access-limited author reports and corrections identified explicitly. Actual March 2022 NHLBI activity definition/types/benefits/risks/stay-active bodies read selectively; risk page incorrectly places myocarditis under congenital problems and that taxonomy is excluded. Population doses, individual event-benefit estimates and vigorous-exercise universal clearance excluded. Actual NHS January 2024 coronary recovery, March 2025 angina, January 2025 AF and June 2026 heart-failure bodies read. Actual September 2026 beta-blocker and July 2026 furosemide bodies read, with selected mechanism/interaction/fluid cautions only; dated September 2024 anticoagulant injury/bleeding and August 2023 hypoglycaemia original read, glucose-page scheduled review overdue. No personal medicine/dose/glucose/fluids or sport-clearance algorithms. Actual CUH June 2025 ICD aftercare reopened for selected healing/activity discussion, with fixed restrictions not adopted. Actual CUH current 2026 pre-assessment/home pages and named ACT video funding read, plus own provider charity description; video routines and donor-allocation claims not adopted. Actual197-page CUH2025–26 accounts reopened, selected PDFpp169–170 operating-income notes read; public/NHS, private/overseas, research/training, donations/leases/services separate. Actual August 2026 ESC original selected preamble/safety/uncertainty passages read, society development finance stated and actual current institutional income body reopened; full separate author declarations and source-trial financial chains not retrieved. No new systematic efficacy estimate. Clinical source use remains bounded. Guidance, classification, emergency education and independent efficacy are distinct source roles. A full systematic review, complete society donor audit and author-by-author clearance of original treatment trials were not completed.
Last reviewed: October 4, 2026. Educational information, not a diagnosis or personal treatment plan. Use your local emergency service for an emergency.
Have a question — or want us to cover something?
Ask about anything on this page, or request the next deep dive: an ingredient, a supplement, or a health concern. We use published research, evidence syntheses, and regulatory guidance, with clear source links.
One daily research roundup
Get the topics, key findings and links from our new articles in one email. At most one digest a day, only when there is something new.